Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2018 1
2019 2
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment.
Blinova E, Roshchin D, Kogan E, Samishina E, Demura T, Deryabina O, Suslova I, Blinov D, Zhdanov P, Osmanov U, Nelipa M, Kaprin A. Blinova E, et al. Among authors: Roshchin D. Cells. 2019 May 31;8(6):526. doi: 10.3390/cells8060526. Cells. 2019. PMID: 31159302 Free PMC article.
Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells.
Makhov PB, Golovine KV, Kutikov A, Canter DJ, Rybko VA, Roshchin DA, Matveev VB, Uzzo RG, Kolenko VM. Makhov PB, et al. Among authors: Roshchin DA. Carcinogenesis. 2011 Dec;32(12):1773-81. doi: 10.1093/carcin/bgr212. Epub 2011 Sep 22. Carcinogenesis. 2011. PMID: 21940908 Free PMC article.
Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy.
Blinova E, Enikeev D, Roshchin D, Samyshina E, Deryabina O, Tertychnyy A, Blinov D, Kogan E, Dudina M, Barakat H, Merinov D, Kachmazov A, Serebrianyi S, Potoldykova N, Perepechin D. Blinova E, et al. Among authors: Roshchin D. Cancers (Basel). 2020 May 21;12(5):1316. doi: 10.3390/cancers12051316. Cancers (Basel). 2020. PMID: 32455829 Free PMC article.
Feedback